Business Context and Reporting Period
Company: Pavmed Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 16, 2021
Reporting Period: Single event date (February 16, 2021)
Business Context: Pavmed Inc. is an emerging growth company focused on minimally invasive medical devices. The filing reports a significant clinical milestone regarding its CarpX device.
Key Financial Metrics
This filing is a current report regarding a specific corporate event and does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes
The material change reported is a clinical milestone rather than a financial adjustment:
- Clinical Milestone: The first U.S. patient recently underwent a successful carpal tunnel release using Pavmed's CarpX minimally invasive carpal tunnel device.
- Disclosure Method: The company issued a press release (attached as Exhibit 99.1) to announce this event under Regulation FD.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release detailing the successful procedure but does not include forward-looking guidance, financial outlook, or specific management commentary within the body of the 8-K text.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing. The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the full text of the press release attached as Exhibit 99.1 for details on the clinical procedure and patient outcomes.
- Confirm the regulatory status and FDA clearance timeline for the CarpX device following this first U.S. use.
- Review subsequent filings (e.g., 10-Q or 10-K) for financial impact or commercialization plans related to this milestone.
- Check for any updates on the Series Z (PAVMZ) and Series W (PAVMW) warrants listed on Nasdaq.